We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Relaxin, Its Receptor (RXFP1), and Insulin-Like Peptide 4 Expression Through Gestation and in Placenta Accreta.
- Authors
Goh, William; Yamamoto, Sandra Y.; Thompson, Karen S.; Bryant-Greenwood, Gillian D.
- Abstract
This study was designed to show whether placental relaxin (RLN), its receptor (RXFP1), or insulin-like peptide 4 (INSL4) might have altered expression in patients with placenta accreta. The baseline expression of their genes through gestation (n = 34) was quantitated in the placental basal plate (BP) and villous trophoblast (TR), and compared to their expression in placenta accreta (n = 6). The proteins were also immunolocalized and quantitated in the accreta tissues. The messenger RNAs (mRNAs) of matrix metalloproteinase 9, -2, and tissue inhibitors of matrix metalloproteinase (TIMP)-1 were also measured. Results demonstrated that the BP and TR expressed low levels of RLN/RXFP1 and INSL4 through gestation. In accreta, increased RLN gene and protein in BP were associated with antepartum bleeding whereas INSL4 expression decreased throughout the TR. There were no changes in mRNAs for MMPs, but TIMP-1 was increased only in the invasive TR.
- Subjects
RELAXIN; PREGNANCY complications; TROPHOBLAST; MESSENGER RNA; MATRIX metalloproteinases; PLACENTA abnormalities
- Publication
Reproductive Sciences, 2013, Vol 20, Issue 8, p968
- ISSN
1933-7191
- Publication type
Article
- DOI
10.1177/1933719112472735